Alan Russell:讲人体的再生
Alan Russell研究的是再生医学 - 以一种突破性的思维方式去看待疾病与损伤，以一种方式向人体发送信号诱导其进行自我修复。
专访Illumina高层：创新引领Illumina前行
生物谷专访了Illumina全球副总裁兼首席商务官Tristan Orpin先生和亚太区总裁Tim Orpin先生，就行业人士广泛关注的罗氏收购Illumina事件、个体化医疗与测序行业发展，Illumina的新产品和技术及市场战略，与这对双胞胎总裁作了深入交流。
Interplays between Mesenchymal Stem Cells and Immune Responses
Mesenchymal stem cells (MSCs) exist in almost all tissues and are crucial in maintaining the cellular homeostasis of multicellular organisms. They provide the ultimate cell source for tissue repair and regeneration. Under pathological conditions, these cells are awakened, activated, and mobilized to damaged tissue sites. Since tissue damages are often accompanied by inflammatory factors, from both innate immune response and adaptive immune response, it is sensible that MSCs delicately interact with inflammatory factors at the sites of tissue damages.
Depending on the type and persistence of the inflammatory factors, the activated MSCs could lead either to complete or partial tissue repair, or to chronic inflammation and further tissue damage, such as cancer and fibrosis. Indeed, recent studies have shown that there is a bidirectional interaction between MSCs and inflammatory cells and cytokines. However, much information of this information remains to be elucidated. Further investigations in this newly emerging exciting research area will undoubtedly lead to better understanding of pathogenesis of various diseases and novel treatment strategies.
Cell and chemical biology of mitosis
Cell and chemical biology of mitosis
Cell and chemical biology of mitosis
Cell and chemical biology of mitosis
Targets-based therapy for leukemia: opportunity and challenge
优点主要为：能增强患者的免疫力，防止肿瘤的转移和复发，对病人机体的损伤小。 在我国，现在普遍开展的树突状细胞（DC）和细胞因子诱导的杀伤细胞（CIK）的生物疗法被广泛应用。